Skip to main content

Table 2 Difference between baseline and final BCVA

From: A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases

 

Baseline

Final

Difference

Test value

P-value

BCVA

 Mean ± SD

0.16 ± 0.08

0.60 ± 0.23

0.44 ± 0.19

− 3.633 ≠ 

 < 0.001

 Range

0.1–0.32

0.32–1

0.22–0.7

 Range

213–660

208–619

− 370–309

  1. BCVA best-corrected visual acuity, SD standard deviation
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us